{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T08:02:13Z","timestamp":1783238533233,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.clindermatol.2024.12.011","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T03:38:29Z","timestamp":1734233909000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mixed and undifferentiated autoimmune connective tissue diseases"],"prefix":"10.1016","volume":"43","author":[{"given":"Matthew D.","family":"Vesely","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2024.12.011_bib0001","series-title":"Skin Signs of Systemic Disease","first-page":"448","author":"Braverman","year":"1970"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0003","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/14397595.2019.1709944","article-title":"2019 diagnostic criteria for mixed connective tissue disease (MCTD): from the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases","volume":"31","author":"Tanaka","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0004","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1136\/jcp.54.5.340","article-title":"Autoantibodies and overlap syndromes in autoimmune rheumatic disease","volume":"54","author":"Jury","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0005","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/rheumatology\/33.12.1117","article-title":"Long-term follow-up of 46 patients with anti-(U1)snRNP antibodies","volume":"33","author":"van den Hoogen","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0006","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s10067-022-06286-w","article-title":"The enigma of mixed connective tissue disease-challenges in routine care","volume":"41","author":"Wanzenried","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0007","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13075-017-1494-7","article-title":"Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study","volume":"19","author":"Reiseter","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0008","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/acr.24167","article-title":"Clinical features of systemic sclerosis-mixed connective tissue disease and systemic sclerosis overlap syndromes","volume":"73","author":"Fairley","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1961.01580150005001","article-title":"Systemic scleroderma, a clinical study of 727 cases","volume":"84","author":"Tuffanelli","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0010","series-title":"Skin Signs of Systemic Disease","first-page":"653","author":"Braverman","year":"1998"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0011","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1093\/rheumatology\/keac165","article-title":"Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD","volume":"61","author":"Todoroki","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0012","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0019-5154.123491","article-title":"Cutaneous manifestations of mixed connective tissue disease: study from a tertiary care hospital in eastern India","volume":"59","author":"Sen","year":"2014","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0013","series-title":"proceedings of the International Symposium on Mixed Connective Tissue Disease and Anti-nuclear Antibodies, Tokyo, 29-30 August 1986","first-page":"357","article-title":"Mixed connective tissue disease and anti-nuclear antibodies","author":"Kasukawa","year":"1987"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00296-022-05161-w","article-title":"The diagnostic challenge of patients with anti-U1-RNP antibodies","volume":"43","author":"Elhani","year":"2023","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-021-00710-2","article-title":"Differentiating between UCTD and early-stage SLE: from definitions to clinical approach","volume":"18","author":"Sciascia","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0016","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48-49","author":"Mosca","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0017","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/0961203316671814","article-title":"Application of SLICC classification criteria in undifferentiated connective tissue disease and evolution in systemic lupus erythematosus: analysis of a large monocentric cohort with a long-term follow-up","volume":"26","author":"Bortoluzzi","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0018","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sjogren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0019","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3899\/jrheum.090804","article-title":"Secondary Sjogren's syndrome in systemic lupus erythematosus defines a distinct disease subset","volume":"37","author":"Baer","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/RHU.0b013e31823ecbdf","article-title":"Systemic lupus erythematosus with Sjogren syndrome compared to systemic lupus erythematosus alone: a meta-analysis","volume":"18","author":"Yao","year":"2012","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0021","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/rheumatology\/39.6.603","article-title":"How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)","volume":"39","author":"Young","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0022","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/ard.62.9.897","article-title":"Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity","volume":"62","author":"Carmona","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0023","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3899\/jrheum.090815","article-title":"Associated autoimmune diseases in systemic sclerosis define a subset of patients with milder disease: results from 2 large cohorts of European Caucasian patients","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0024","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","article-title":"Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients","volume":"75","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0025","first-page":"S52","article-title":"Skin involvement and outcome measures in systemic autoimmune diseases","volume":"24","author":"Albrecht","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0026","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","article-title":"Characterization of systemic disease in primary Sjogren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements","volume":"54","author":"Ramos-Casals","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0027","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjogren's syndrome: results of a large multicentre study","volume":"44","author":"Quartuccio","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","article-title":"Early diagnosis of primary Sjogren's syndrome: EULAR-SS task force clinical recommendations","volume":"12","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0029","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0190-9622(89)70333-9","article-title":"Annular erythema associated with primary Sjogren syndrome: analysis of T cell subsets in cutaneous infiltrates","volume":"21","author":"Katayama","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0030","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0190-9622(89)70070-0","article-title":"Annular erythema: a possible association with primary Sjogren's syndrome","volume":"20","author":"Teramoto","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0031","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5021\/ad.2014.26.2.203","article-title":"Immunohistochemical analysis of interleukin-17 producing T helper cells and regulatory T cells infiltration in annular erythema associated with Sjogren's syndrome","volume":"26","author":"Itoi","year":"2014","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0032","first-page":"340","article-title":"Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome","volume":"48","author":"McDuffie","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2024.12.011_bib0033","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0190-9622(92)70069-R","article-title":"Urticarial vasculitis: a histopathologic and clinical review of 72 cases","volume":"26","author":"Mehregan","year":"1992","journal-title":"J Am Acad Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X24002761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T14:32:45Z","timestamp":1744986765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X24002761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0738081X24002761"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.011","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mixed and undifferentiated autoimmune connective tissue diseases","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2024.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}